April 17, 2007
$10.5 Million for Resolution Related to Marketing of Cancer Drug
A DOJ Press Release reports that "Cell Therapeutics Inc. (CTI) of Seattle, Wash., has agreed to pay the United States $10.5 million to resolve allegations of the company’s illegal marketing of the anti-cancer prescription drug Trisenox." This case was resolved by the Department of Justice within the civil division.
TrackBack URL for this entry:
Listed below are links to weblogs that reference $10.5 Million for Resolution Related to Marketing of Cancer Drug: